Applied DNA Sciences (APDN)
(Delayed Data from NSDQ)
$4.37 USD
-0.63 (-12.60%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $4.36 -0.01 (-0.23%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$4.37 USD
-0.63 (-12.60%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $4.36 -0.01 (-0.23%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Zacks News
Allegion (ALLE) Q1 Earnings Surpass Estimates
by Zacks Equity Research
Allegion (ALLE) delivered earnings and revenue surprises of 9.93% and 2.33%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Is Applied DNA Sciences (APDN) Outperforming Other Industrial Products Stocks This Year?
by Zacks Equity Research
Here is how Applied DNA Sciences (APDN) and Encore Wire (WIRE) have performed compared to their sector so far this year.
Applied DNA Sciences (APDN) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Applied DNA Sciences (APDN) delivered earnings and revenue surprises of 70.97% and 27.29%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
ADT (ADT) Q2 Earnings and Revenues Miss Estimates
by Zacks Equity Research
ADT (ADT) delivered earnings and revenue surprises of -30.43% and 2.88%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Proto Labs (PRLB) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Proto Labs (PRLB) delivered earnings and revenue surprises of 10% and 0.12%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Kennametal (KMT) Q4 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Kennametal (KMT) delivered earnings and revenue surprises of -16.39% and 2.86%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Alarm.com Holdings (ALRM) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Alarm.com (ALRM) delivered earnings and revenue surprises of 36.67% and 1.17%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Clear Secure (YOU) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Clear Secure (YOU) delivered earnings and revenue surprises of 300% and 2.03%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Napco (NSSC) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Napco (NSSC) delivered earnings and revenue surprises of 52.63% and 3.25%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
What Makes Applied DNA Sciences (APDN) a New Buy Stock
by Zacks Equity Research
Applied DNA Sciences (APDN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
RBC Bearings (RBC) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
RBC Bearings (RBC) delivered earnings and revenue surprises of 7.82% and 2.17%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Alta Equipment (ALTG) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Alta Equipment (ALTG) delivered earnings and revenue surprises of 16.67% and 5.39%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Alarm.com Holdings (ALRM) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Alarm.com (ALRM) delivered earnings and revenue surprises of 10% and 2.62%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Applied DNA Sciences (APDN) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Applied DNA Sciences (APDN) delivered earnings and revenue surprises of 8.33% and 19.33%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Energous (WATT) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Energous (WATT) delivered earnings and revenue surprises of 12.50% and 22.63%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
ADT (ADT) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
ADT (ADT) delivered earnings and revenue surprises of 20% and 3.16%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Applied DNA Sciences (APDN) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Applied DNA Sciences (APDN) delivered earnings and revenue surprises of 6.67% and 32.19%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for February 15th
by Zacks Equity Research
ATGE, ALGN, and APDN have been added to the Zacks Rank #5 (Strong Sell) List on February 15, 2022
Applied DNA Sciences (APDN) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Applied DNA Sciences (APDN) delivered earnings and revenue surprises of -231.58% and 2.62%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Napco (NSSC) Lags Q2 Earnings Estimates
by Zacks Equity Research
Napco (NSSC) delivered earnings and revenue surprises of -66.67% and 6.70%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Applied DNA Sciences (APDN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Applied DNA Sciences (APDN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Johnson Controls (JCI) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Johnson Controls (JCI) delivered earnings and revenue surprises of 1.89% and 1.64%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Applied DNA Sciences (APDN) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Applied DNA Sciences (APDN) delivered earnings and revenue surprises of -53.13% and 5.56%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Applied DNA Sciences (APDN) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
Applied DNA Sciences (APDN) delivered earnings and revenue surprises of -91.67% and -50.51%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Will Applied DNA Sciences (APDN) Report Negative Q3 Earnings? What You Should Know
by Zacks Equity Research
Applied DNA Sciences (APDN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.